Search

everythinglearnresearchcommunity

for

Search:↓

ICAM-1 helps regulate hair growth cycles and skin remodeling.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Acute illnesses like sepsis can disrupt thyroid hormone balance without central hypothyroidism.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Human TMEM2 does not break down hyaluronan but helps control its metabolism.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

18β-glycyrrhetinic acid from licorice root is good for skin and hair treatments but has absorption challenges.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

PRP treatment may help with alopecia areata, especially in newer cases.